Publicaciones en las que colabora con JUAN VICENTE ESPLUGUES MOTA (26)

2024

  1. Bictegravir alters glucose tolerance in vivo and causes hepatic mitochondrial dysfunction

    Antiviral Research, Vol. 231

2023

  1. Abacavir causes leukocyte/platelet crosstalk by activating neutrophil P2X7 receptors thus releasing soluble lectin-like oxidized low-density lipoprotein receptor-1

    British Journal of Pharmacology, Vol. 180, Núm. 11, pp. 1516-1532

  2. P2X7 Receptor Regulates Collagen Expression in Human Intestinal Fibroblasts: Relevance in Intestinal Fibrosis

    International Journal of Molecular Sciences, Vol. 24, Núm. 16

2022

  1. Macrophages Modulate Hepatic Injury Involving NLRP3 Inflammasome: The Example of Efavirenz

    Biomedicines, Vol. 10, Núm. 1

2021

  1. Abacavir Increases Purinergic P2X7 Receptor Activation by ATP: Does a Pro-inflammatory Synergism Underlie Its Cardiovascular Toxicity?

    Frontiers in Pharmacology, Vol. 12

2020

  1. Differential Effects of Biologics on Psoriasis-Related Vascular Inflammation and Risk of Thrombosis

    Journal of Investigative Dermatology, Vol. 140, Núm. 11, pp. 2294-2298.e6

  2. Leukocyte–Endothelium Interaction Is Associated with Fat Mass in Children

    Journal of Pediatrics, Vol. 221, pp. 181-187.e1

2018

  1. Abacavir induces arterial thrombosis in a murine model

    Journal of Infectious Diseases

2017

  1. Abacavir induces platelet-endothelium interactions by interfering with purinergic signalling: A step from inflammation to thrombosis

    Antiviral Research, Vol. 141, pp. 179-185

  2. Cardiovascular toxicity of abacavir: A clinical controversy in need of a pharmacological explanation

    AIDS, Vol. 31, Núm. 13, pp. 1781-1795

2016

  1. Aspirin-induced gastrointestinal damage is associated with an inhibition of epithelial cell autophagy

    Journal of Gastroenterology, Vol. 51, Núm. 7, pp. 691-701

  2. Interference with purinergic signalling: An explanation for the cardiovascular effect of abacavir?

    AIDS, Vol. 30, Núm. 9, pp. 1341-1351

2015

  1. Differential effects of anti-TNF-α and anti-IL-12/23 agents on human leukocyte-endothelial cell interactions

    European Journal of Pharmacology, Vol. 765, pp. 355-365

  2. Efavirenz and the CNS: What we already know and questions that need to be answered

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 10, pp. 2693-2708

2014

  1. Efavirenz induces interactions between leucocytes and endothelium through the activation of Mac-1 and gp150,95

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 4, pp. 995-1004

  2. Neuronal bioenergetics and acute mitochondrial dysfunction: A clue to understanding the central nervous system side effects of efavirenz

    Journal of Infectious Diseases, Vol. 210, Núm. 9, pp. 1385-1395

  3. Progastrin represses the alternative activation of human macrophages and modulates their influence on colon cancer epithelial cells

    PLoS ONE, Vol. 9, Núm. 6

2013

  1. M2 Macrophages Activate WNT Signaling Pathway in Epithelial Cells: Relevance in Ulcerative Colitis

    PLoS ONE, Vol. 8, Núm. 10

  2. Profile of leukocyte-endothelial cell interactions induced in venules and arterioles by nucleoside reverse-transcriptase inhibitors in vivo

    Journal of Infectious Diseases

2012

  1. Differential effects of tenofovir/emtricitabine and abacavir/lamivudine on human leukocyte recruitment

    Antiviral Therapy, Vol. 17, Núm. 8, pp. 1615-1619